Bradley Sloan
Managing Partner @ Questa Capital Management
San Francisco, United States
Bradley Sloan is a Series B investor at Questa Capital Management in San Francisco focused on Health Care and Information Technology. Bradley Sloan - Managing Partner @ Questa Capital Management
- Total investments:
- 5
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Bradley Sloan invests in
Stages Bradley Sloan invests in
Countries Bradley Sloan invests in
Investment Focus
Industry
- Health Care 4 (80%)
- Information Technology 3 (60%)
- Hospital 2 (40%)
- FinTech 1 (20%)
- Finance 1 (20%)
Stage
- Series B 2 (40%)
- Series C 1 (20%)
- Funding Round 1 (20%)
- Private Equity 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PatientFi
|
PatientFi is a financial services company to helps patients to access the current health, beauty, and wellness treatments. It features a point-of-sale technology platform that partners with medical practices to offer their patients personalized financing plans to pay for elective procedures.The company was founded in 2017 and headquartered inCalifornia, United States. | $25M / Series B / Feb 13, 2024 | |
VyncaCare
|
VyncaCare provides palliative care, advanced care planning, and enhanced care management services. | $30M / Series C / Jan 07, 2022 | |
Claritas Rx
|
Claritas Rx is a data integration and analytics company for pharmaceutical manufacturers. It leverages a proprietary technology platform and deep manufacturer expertise to automate and integrate channel, commercial, and clinical data and help biopharmaceutical companies generate actionable business insights. | Private Equity / Mar 09, 2021 | |
andros
|
andros is an NCQA-certified Credentials Verification Organization and technology-enabled provider network management solutions company. The credentialing segment of the business combines software and services to help payers and provider organizations to eliminate compliance risk, streamline operations and manage their providers better. The NetworkDevelopment segment of the business utilizes proprietary data sets, technology and subject matter expertise to build and manage provider networks that control costs, ensure compliance and deliver value for local, regional and national health plans. | $14M / Series B / Jun 12, 2019 | |
Cortica
|
Cortica is a rapidly growing healthcare company pioneering a unique and effective approach to treating neurodevelopmental conditions including autism spectrum disorder, speech and language delays, sensory processing disorder and other conditions that impact brain development. Harnessing insights and technologies from emerging neuroscience, Corticabrings together clinical specialists from a range of disciplines to design and deliver comprehensive care to children with developmental differences. | Nov 13, 2018 |
Co-Investors
About Questa Capital Management
Questa Capital Management is a healthcare venture growth equity firm investing in breakout growth companies.
Questa Capital Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Aabed Meer
Partner
|
|||
Bradley Sloan
Managing Partner
|
|||
|
Bradley Sloan
Managing Partner
|
|||
Brian L. Butler
Vice President
|
|||
Ryan Drant
Founder & Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bradley Sloan invest in?
Bradley Sloan invests primarily in Health Care, Information Technology and Hospital startups, most often at Series B and Series C stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Bradley Sloan last invest?
The most recent investment recorded for Bradley Sloan closed in Feb 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
